We are live on
!
Find out more
AB
Amalgamated Bank Portfolio holdings
AUM
$14.5B
1-Year Est. Return
44.3%
This Fund
S&P 500
This Quarter
Est. Return
+0.49%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$11.8B
AUM Growth
-$631M
(-5.1%)
Cap. Flow
-$566M
Cap. Flow
% of AUM
-4.78%
Top 10 Holdings %
Top 10 Hldgs %
19.95%
Holding
2,211
New
30
Increased
190
Reduced
1,934
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$20.2M |
| 2 |
Match Group
MTCH
|
+$6.61M |
| 3 |
Analog Devices
ADI
|
+$6.39M |
| 4 |
GXO Logistics
GXO
|
+$5.97M |
| 5 |
JHG
Janus Henderson
JHG
|
+$5.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$23.2M |
| 2 |
Microsoft
MSFT
|
+$23.2M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$11.6M |
| 4 |
Amazon
AMZN
|
+$11.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$9.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.59% |
| 2 | Financials | 14.53% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 12.03% |
| 5 | Industrials | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
MP Materials
MP
$7.35B
| $418K | ﹤0.01% |
12,979
-798
| -6% | -$27.8K |
|
1677
Standard Motor Products
SMP
$897M
| $417K | ﹤0.01% |
9,541
-512
| -5% | -$22K |
|
1678
Celldex Therapeutics
CLDX
$2.79B
| $416K | ﹤0.01% |
7,705
+704
| +10% | +$33K |
|
1679
Domo
DOMO
$170M
| $416K | ﹤0.01% |
4,922
-282
| -5% | -$24.1K |
|
1680
Prothena Corp
PRTA
$448M
| $416K | ﹤0.01% |
5,835
-225
| -4% | -$14K |
|
|
FSR
1681
DELISTED
Fisker Inc.
FSR
| $416K | ﹤0.01% |
28,390
-961
| -3% | -$14.5K |
|
|
TPTX
1682
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $416K | ﹤0.01% |
6,261
-444
| -7% | -$31.6K |
|
|
EFC
1683
Ellington Financial
EFC
$1.7B
| $415K | ﹤0.01% |
22,714
+2,156
| +10% | +$39.6K |
|
|
CUTR
1684
DELISTED
Cutera, Inc.
CUTR
| $413K | ﹤0.01% |
8,864
-692
| -7% | -$34.1K |
|
|
NTUS
1685
DELISTED
Natus Medical Inc
NTUS
| $413K | ﹤0.01% |
16,458
-260
| -2% | -$6.62K |
|
|
TWOU
1686
DELISTED
2U Inc
TWOU
| $411K | ﹤0.01% |
408
-26
| -6% | -$30.5K |
|
1687
Veracyte
VCYT
$4.44B
| $410K | ﹤0.01% |
8,824
-653
| -7% | -$28.5K |
|
1688
DNOW Inc
DNOW
$2.53B
| $409K | ﹤0.01% |
53,519
-847
| -2% | -$6.92K |
|
1689
Zumiez
ZUMZ
$347M
| $409K | ﹤0.01% |
10,285
-168
| -2% | -$7.17K |
|
1690
Organogenesis Holdings
ORGO
$326M
| $408K | ﹤0.01% |
28,678
+4,207
| +17% | +$65.3K |
|
|
MCHB
1691
Mechanics Bancorp
MCHB
$3.51B
| $407K | ﹤0.01% |
9,886
-737
| -7% | -$28.8K |
|
|
VIVO
1692
DELISTED
Meridian Bioscience Inc
VIVO
| $407K | ﹤0.01% |
21,149
-328
| -2% | -$6.54K |
|
1693
Academy Sports + Outdoors
ASO
$3.13B
| $406K | ﹤0.01% |
10,136
+1,450
| +17% | +$57.8K |
|
|
SRDX
1694
DELISTED
Surmodics
SRDX
| $406K | ﹤0.01% |
7,295
-122
| -2% | -$6.78K |
|
1695
Virtu Financial
VIRT
$5.11B
| $406K | ﹤0.01% |
16,626
-1,204
| -7% | -$30.6K |
|
1696
Photronics
PLAB
$1.72B
| $404K | ﹤0.01% |
29,641
-1,457
| -5% | -$19.8K |
|
1697
Genesco
GCO
$432M
| $403K | ﹤0.01% |
6,984
-113
| -2% | -$6.72K |
|
1698
Marathon Digital Holdings
MARA
$4.34B
| $403K | ﹤0.01% |
12,763
-923
| -7% | -$30K |
|
1699
Outset Medical
OM
$87.5M
| $402K | ﹤0.01% |
543
-33
| -6% | -$22.5K |
|
1700
AppFolio
APPF
$6.31B
| $401K | ﹤0.01% |
3,334
-205
| -6% | -$26.6K |
|
Similar funds
JFG
IFP
BBVA
SSA
HIIFS
BGC
Amalgamated Bank's Q3 2021 Portfolio in Review
As of Q3 2021, Amalgamated Bank held 2,211 positions worth $11.8B, down 5.1% from $12.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Amalgamated Bank withdrew a net $566M in Q3 2021, closing 47 positions and reducing 1,934 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $11.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Amalgamated Bank opened a new position in GXO Logistics worth $5.97M.
- Amalgamated Bank's largest Q3 2021 buy was GXO Logistics: 76,088 shares worth $5.97M.
- Amalgamated Bank added most to Moderna in Q3 2021, an estimated $20.2M increase.
- Amalgamated Bank's biggest Q3 2021 reduction was Apple, cutting an estimated $23.2M.
- Amalgamated Bank fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $11.6M.
- Amalgamated Bank's ten largest holdings make up 20% of its $11.8B portfolio in Q3 2021.
- Amalgamated Bank opened 30 new positions and closed 47 in Q3 2021.
- Amalgamated Bank's portfolio value fell 5.1% quarter-over-quarter to $11.8B.
Based on Amalgamated Bank's 13F filing for Q3 2021, filed 29 Oct 2021.